Enabling Scaling Manufacturing of Cell and Gene Therapies by empowering Therapy developers to fully utilise manufacturing capabilities, through innovative software solutions
AutoloMATE's 3 Phased Approach
We have developed our product strategy by leveraging manufacturing insight gained from our combined experience of >45 years within the Cell & Gene Therapy Industry. Each phase has been designed & prioritised based on the current and our perceived future needs of the Cell & Gene Therapy developer and the growth of the industry…. The excitement is building as we join partners to progress along this drug development pathway.
Kwok Pang, COO of Autolomous